BiotechTube

Beriplex

Phase 2UNKNOWN
0 watching 0 views this week⚡ Active
51
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Action Reversal

Conditions

Drug Action Reversal

Trial Timeline

Jan 1, 2015 → Dec 1, 2016

NCT ID
NCT02463591

About Beriplex

Beriplex is a phase 2 stage product being developed by CSL for Drug Action Reversal. The current trial status is unknown. This product is registered under clinical trial identifier NCT02463591. Target conditions include Drug Action Reversal.

Hype Score Breakdown

Clinical
17
Activity
12
Company
9
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02463591Phase 2UNKNOWN

Competing Products

20 competing products in Drug Action Reversal

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
40
GP404141 + NplateGEROPHARMPhase 3
69
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
33
EC905 + verapamilAstellas PharmaPhase 1
33
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
33
enzalutamide + rifampinAstellas PharmaPhase 1
33
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
33
CefiderocolShionogiApproved
85
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
33
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
33
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
33
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
77
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
33
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77

Other Products from CSL

IgPro10Approved
84
four factor prothrombin complex concentrateApproved
84
Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)Approved
84
IgPro10Approved
84
Blood coagulation Factor VIII and vWF, humanApproved
84